No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension

被引：0
|
作者：
Gause-Nilsson, I. [1 ]
Sonesson, C. [1 ]
Johansson, P. A. [1 ]
Johnsson, E. [1 ]
机构：
[1] AstraZeneca, Molndal, Sweden
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
754
引用
收藏
页码：S362 / S363
页数：2
相关论文
共 50 条
  • [31] Blood Pressure Reduction With Dapagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease
    Woo, Vincent
    Leiter, Lawrence A.
    Cefalu, William T.
    de Bruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Parikh, Shamik J.
    Johnsson, Eva
    [J]. CIRCULATION, 2013, 128 (22)
  • [32] Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
    Fujihara, Kazuya
    Sone, Hirohito
    [J]. ANNALS OF VASCULAR DISEASES, 2018, 11 (01) : 2 - 14
  • [33] Cardiovascular risk in type 2 diabetes mellitus
    Hohberg, C.
    Roth, W.
    Luebben, G.
    Forst, T.
    Gauert, S.
    Karagiannis, F.
    Reimer, T.
    Gottschall, V.
    Pfuetzner, A.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 173 - 177
  • [34] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    [J]. CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [35] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [36] Two-year efficacy and safety of dapagliflozin for patients with type 2 diabetes mellitus and a history of cardiovascular disease
    Gause-Nilsson, I.
    DeBruin, T. W.
    Sugg, J.
    Parikh, S. J.
    Johnsson, E.
    Leiter, L. A.
    [J]. DIABETOLOGIA, 2014, 57 : S325 - S325
  • [37] Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
    Lessey, Gayatri
    Stavropoulos, Konstantinos
    Papademetriou, Vasilios
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 365 - 373
  • [38] NOVEL RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE
    Latsabidze, N.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E108 - E108
  • [39] Incident Diabetes Mellitus, Hypertension, and Cardiovascular Disease Risk in Exercising Hypercholesterolemic Patients
    Williams, Paul T.
    Franklin, Barry A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (10): : 1516 - 1520
  • [40] Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease
    Rana, Jamal S.
    Liu, Jennifer Y.
    Moffet, Howard H.
    Sanchez, Robert J.
    Khan, Irfan
    Karter, Andrew J.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2020, 133 (02): : 200 - 206
12345